It is estimated that thirty-five million people worldwide are infected with AIDS, with an additional two million added each year. Experts believe that developing a 'preventive' vaccine is the most effective way to prevent the spread of this disease, ultimately leading to its eradication; whereas creating a vaccine for 'treatment' reduces the effects of the disease, which can aid in its eradication. However, despite thirty years of research and testing to create a preventive vaccine or a drug to lessen the disease's impact, there is still no comprehensive global approach to combat AIDS. Many vaccines and immunogens developed in laboratories have failed in the final stages of testing. Nevertheless, the European Union has made a serious decision to overcome this challenge. According to the EU's information portal, a group of leading vaccination researchers from nine European countries, along with researchers from Australia, Canada, and the United States, have come together. The aim of this scientific group, known as the European AIDS Vaccine Initiative 2020 or EAVI 2010, is to develop an effective vaccine for AIDS by 2020. The EU report states that this group will provide a platform for discovering new and different ways to create preventive or therapeutic vaccines for AIDS. The project's budget of 23 million euros is funded by the 'Europe in Horizon 2010' program. According to United Press, Robin Shattock, a professor at Imperial College London, which will be the main hub for this research, states that 'this project will enable us to move much faster towards developing an effective vaccine. [This project] brings together a group of the best molecular biologists, immune system specialists, virologists, and physicians to provide the necessary expertise for the rapid development of a comprehensive AIDS vaccine.' Shattock notes that developing an effective vaccine against AIDS is one of the greatest challenges for molecular biologists of this generation, and this project is a unique opportunity for scientists to utilize previous research findings to bring an end to the AIDS epidemic.
European Scientists' Plan to Develop an AIDS Vaccine Within '5 Years'
A group of European scientists, along with researchers from Australia, Canada, and the US, has launched the European AIDS Vaccine Initiative 2020 to develop an effective AIDS vaccine within five years. The project, funded by the EU, aims to discover new methods for vaccine development, addressing a critical global health challenge. This initiative is significant as it represents a concerted effort to combat the AIDS epidemic after decades of research without a successful vaccine.
👥 Key Players
📰 What Happened
A group of European and international scientists has launched the European AIDS Vaccine Initiative 2020 to develop an effective AIDS vaccine within five years. This initiative aims to address the ongoing global health challenge of AIDS after decades of unsuccessful vaccine research.
- The project has a budget of 23 million euros funded by the EU's Horizon 2010 program.
- The initiative involves researchers from nine European countries, Australia, Canada, and the United States.
💡 Why It Matters
📚 Background
AIDS remains a major global health issue, with millions infected worldwide and no effective preventive vaccine developed despite extensive research. The need for a comprehensive approach to combat the disease is urgent.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%